Showing results 5 to 5 of 5
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 |